LINTRUZA Trademark

Trademark Overview

On Sunday, July 3, 2016, a trademark application was filed for LINTRUZA with the United States Patent and Trademark Office. The USPTO has given the LINTRUZA trademark a serial number of 87092197. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2019. This trademark is owned by Dyax Corp.. The LINTRUZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hereditary angioedema
lintruza

General Information

Serial Number87092197
Word MarkLINTRUZA
Filing DateSunday, July 3, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hereditary angioedema

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 7, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDyax Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDyax Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Monday, August 12, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 12, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 31, 2018EXTENSION 3 GRANTED
Monday, December 31, 2018EXTENSION 3 FILED
Monday, December 31, 2018TEAS EXTENSION RECEIVED
Friday, August 10, 2018ASSIGNED TO EXAMINER
Saturday, June 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 28, 2018EXTENSION 2 GRANTED
Thursday, June 28, 2018EXTENSION 2 FILED
Thursday, June 28, 2018TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 27, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 7, 2018EXTENSION 1 GRANTED
Sunday, January 7, 2018EXTENSION 1 FILED
Sunday, January 7, 2018TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 1, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, December 14, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 13, 2016ASSIGNED TO EXAMINER
Thursday, July 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, July 6, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

lintruza angioedema hereditary treatment preparations pharmaceutical